- Benchmark ASINB0G3R4S426
- MarketplaceUS
- Category ID3760901
- Analyzed Products
- Keywordnitric oxide supplement, beet root supplement
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-26
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入。 新品表面还有利润空间，但已经被老品牌和一批高投入新品牌挤得很紧；对小商家尤其不友好，想赢基本要靠更激进的打法，不是正常上架就能跑出来。
证据很直接： 目前单个新ASIN的推荐启动预算大约在 2381.49~24961.9 美元，用户预算 50万人民币 表面上能覆盖单品起步，但这不等于能拿到胜率。市场里新品牌一共 12个，新品牌新品成功率只有 43.48%，并没有低到“彻底不能做”，但失败样本也很多；更关键的是，老品牌成功更强，HumanN 这类老牌有 66.67% 的整体盈利率，月收入样本高达 16323.15万美金，而且像 B0GCC3S9C5 这种新款月销约 15.8万美金、利润率 37.08%，说明真正吃到大盘的还是品牌力玩家。新品利润区间大约在 29.71%~38.54%，看着不差，但近一年新产品里 56.52% 是不赚钱的，已经是明显的流量争夺和价格挤压区，不是宽松红利市场。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：这个市场现在不值得进入，尤其对小商家更不友好。 你的预算50万人民币足够覆盖少数新ASIN的前期铺货与投放，但市场里新品牌和老品牌都在用高投入抢位，且新品成功率并不高，已经呈现明显的价格与流量竞争压力。
Early sourcing + logistics + marketing budget (USD)$2,381.49 - $24,961.90Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?52.00%New listing success rate (old brands):38.46%New listing success rate (new brands):43.48%Which new brands have these successful new listings?...Which old brands have these successful new listings?...Alternatives- 甜菜根粉（无胶囊/无糖版本）——通常更便宜、剂量可自行调节，适合已经有摇杯或果汁习惯的人；在“氮氧化物支持”上与胶囊/软糖同类，但使用门槛更低，适合对价格敏感的用户。
- 富含硝酸盐的即饮/即冲运动饮料粉（以甜菜根为主）——如果用户购买目的是训练前表现，这类产品往往比功能型胶囊更容易被接受，且可与电解质一起使用，属于更省事的替代方案。
- 南瓜籽/石榴/葡萄籽复配的基础血流支持配方——这类产品常比“高倍浓缩甜菜根”更平价，且卖点更贴近日常循环与抗氧化维护，适合不追求高剂量甜菜根的人。
- L-瓜氨酸粉末——通常单次成本较低、起效路径明确，且比甜菜根软糖更容易做成训练前常规补给；对于主要想要血流和耐力支持的用户，是更直接的功能替代。
- L-精氨酸基础补充剂——价格常较低、渠道更广，适合想要‘一瓶解决’血流/泵感诉求但不想购买甜菜根类产品的用户，尤其在健身场景里更容易理解和接受。
- 电解质粉/运动补水粉（不含甜菜根）——如果用户购买甜菜根主要是为了‘精力’和运动状态，这类产品通常更便宜、更容易买到，且使用方式简单，能以补水和体感改善替代一部分感知收益。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：新品利润看起来不差，但竞争已经很挤，且真实可复制的小品牌成功样本太少，整体更像被大牌和高强度营销挤压的价格战市场。 用户预算 50万 CNY 对单个 ASIN 来说足够覆盖前期起步，但在这里并不能换来安全边际；真正能跑出来的，基本都要靠老品牌势能、明确差异化，或者更激进的营销手段。\n\n从数据看，市场盈利率约 63.85%，新品盈利率约 40.00%，表面不差；但你要看的不是“能不能赚钱”，而是“谁能赚钱”。样本里老品牌 HumanN、NOW Foods、Force Factor、Snap Supplements 这类老牌，成功 ASIN 的利润率大多在 37%~42%，例如 HumanN 的 B0GCC3S9C5 月销约 15.8万 USD、利润率 37.08%，B07SRK1F3Y 月销约 11.85万 USD、利润率 39.53%；这些是大品牌打法，不适合小品牌照抄。真正可参考的小品牌成功案只有少数：Plutarn B0GRC5YHC7，预算约 7131.97 USD，售价 28.99 USD，月销约 28990 USD，利润率 37.9%；Lemeli B0GRHBMPV4，预算约 24961.90 USD，售价 28.99 USD，月销约 20293 USD，利润率 37.9%；CFILIHTC B0FT7SVVX7 预算约 2083.35 USD，但虽然利润率 22.7%，月销只有约 3998 USD，而且它的失败款 B0GDF8VSB4 直接验证了“配方堆料但没差异化”会死。\n\n更关键的是，市场里已经出现明显的流量和品牌挤压：样本中新品牌里成功/失败并不稳定，像 CFILIHTC 是 1/3 盈利，ProSupps 甚至 0/1 盈利，而 LEMEli、Plutarn 这类新品牌能成，靠的不是普通甜菜根补剂，而是剂型差异化（胶囊/软糖/咀嚼片）+ 明确功能组合 + 低门槛价格。同时，很多失败款都不是因为毛利不够，而是缺少独特卖点、和竞品高度相似。我没有看到“30~100+ 新品牌涌入”的证据，但市场已经明显拥挤，且老品牌与新品牌都在同一功能带内互相内卷，所以这是一个高竞争、低容错的市场。\n\n结论：不要进入。 如果一定要做，唯一可抄的方向是：小品牌只考虑像 B0GRC5YHC7 / B0GRHBMPV4 / B0FT7SVVX7 这种“单点差异化剂型 + 明确人群 + 25美元左右定价”的路线；大品牌才适合对标 HumanN B0GCC3S9C5 / B07SRK1F3Y 这种高品牌力高销量款。其余同质化甜菜根/一氧化氮复配，尤其是像 B0GDF8VSB4、B0GWL65LSC、B0GXGTMVCV 这类，应该直接避开。
New products with Highest revenuePlutarn
Recent Monthly Revenue (USD):$28,990.00(1000pcs/month)B0GRC5YHC7 (4.2/5 (106 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsHumanN
Recent Monthly Revenue (USD):$1,185,000.00(30000pcs/month)B07SRK1F3Y (4.5/5 (75423 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (USD):$224,160.00(6000pcs/month)B01ENMEXO4 (4.2/5 (27964 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (USD):$158,000.00(4000pcs/month)B0GCC3S9C5 (4.6/5 (423 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableLeast investment in new productsCFILIHTC
Recent Monthly Revenue (USD):$3,998.00(200pcs/month)B0FT7SVVX7 (4.7/5 (72 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatThis listing is deemed profitableMost investment in new productsLemeli
Recent Monthly Revenue (USD):$20,293.00(700pcs/month)B0GRHBMPV4 (4.2/5 (74 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableLeast profitable new productsProSupps
Recent Monthly Revenue (USD):-(-)B0GXGTMVCVBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 软糖剂型，和胶囊/粉剂差异最大
- |
- 洋红色包装+莓果图案，视觉最醒目
- |
- 零食感便携装，适合不爱吞胶囊的人群
B0FT7SVVX7 (4.7/5 (72 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatThis listing is deemed profitableSales & BSR
Differentiation:- 独立包装咀嚼片，形态更像零食
- |
- 巧克力口味+棕色包装，和传统补剂区分明显
- |
- 便携即食，适合随身补充
B0GSCQ7C6S (4.6/5 (7 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不适合进入：新品牌成功率不低，但竞争已经明显偏向强品牌和高投放玩家，低利润段占比也很高。 从数据看，整体盈利产品占63.85%，但新产品里真正能稳定盈利的只有40%，而非盈利新产品占到了48%；更关键的是，旧品牌占新产品的比例高达52%，说明新机会被老牌子大量吃掉，已经不是轻松切入的阶段。
Profitability difficultyModerate Risk - Accessible for new brands but oversaturated with new releasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0F161HQ6CRosabella2025-03-11Yes$33.5440000pcs$1341600.040.8%$547372.8B07SRK1F3YHumanN2019-06-24Yes$39.530000pcs$1185000.039.53%$468430.5
B081K83ZQ1Nature's Pure Blend2019-11-15Yes$39.996000pcs$239940.041.88%$100486.88B01ENMEXO4HumanN2016-09-01Yes$37.366000pcs$224160.041.56%$93160.9
B0DW5H679TSnap Supplements2025-02-04Yes$37.735000pcs$188650.038.71%$73026.42
B09GDXCY4JSnap Supplements2018-08-20Yes$31.336000pcs$187980.037.51%$70511.3
B07GQ4Z1L8Snap Supplements2018-08-21Yes$23.878000pcs$190960.036.76%$70196.9B0GCC3S9C5HumanN2025-12-23Yes$39.54000pcs$158000.037.08%$58586.4
B0CV66J8L7VitaUp2024-02-07Yes$24.624000pcs$98480.034.23%$33709.71
B0FV3PCRY4Nature's Pure Blend2025-10-09Yes$39.992000pcs$79980.041.88%$33495.63
B076CRGF8HJacked Factory2017-10-11Yes$27.613000pcs$82830.038.32%$31740.46B0DK5VBB21NUTRAHARMONY2024-08-01Yes$22.113350pcs$74068.533.37%$24716.66
B0013OVX3UNOW Foods2011-04-09Yes$17.036000pcs$102180.024.13%$24656.04
B0GY1QYK5GForestLeaf2026-04-21Yes$34.511450pcs$50039.539.1%$19565.45
B00NBCVVWABulkSupplements2014-09-05Yes$35.152000pcs$70300.026.61%$18706.83
B0BQP44PPSDORADO NUTRITION2023-08-09Yes$17.954000pcs$71800.024.18%$17361.24
B0CZGHL1TWDEAL SUPPLEMENT2024-03-29Yes$19.543000pcs$58620.029.25%$17146.35
B0BYG517XYHumanN2023-03-14Yes$39.2850pcs$33320.038.77%$12918.17
B09K2PF3WQSnap Supplements2021-10-21Yes$20.912000pcs$41820.030.34%$12688.19
B07WK4H9KMJacked Factory2019-08-15Yes$22.02000pcs$44000.028.66%$12610.4Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GCC3S9C5HumanN2025-12-23Yes$39.54000pcs$158000.037.08%$58586.4B0FV3PCRY4Nature's Pure Blend2025-10-09Yes$39.992000pcs$79980.041.88%$33495.63B0GY1QYK5GForestLeaf2026-04-21Yes$34.511450pcs$50039.539.1%$19565.45B0GRC5YHC7Plutarn2026-03-05Yes$28.991000pcs$28990.037.88%$10981.42B0G3R4S426Berkeley Life2025-12-01Yes$29.71800pcs$23768.038.4%$9126.92B0GRHBMPV4Lemeli2026-03-06Yes$28.99700pcs$20293.037.9%$7691.05
B0FK3GPZNXetheray2025-07-27Yes$37.63400pcs$15052.039.87%$6001.24
B0FBBL6DBSNutraChamps2026-01-13Yes$18.851000pcs$18850.030.64%$5775.64
B0FL73X1KNWiszeen2025-08-05Yes$32.99500pcs$16495.033.8%$5575.31B0GSCQ7C6SHumanN2026-03-12Yes$39.95300pcs$11985.032.64%$3911.91
B0GJ6KGDHYVitaUp2026-03-21Yes$21.91400pcs$8764.033.21%$2910.53
B0G34PFH91EnvyCure2025-12-07Yes$36.99200pcs$7398.034.22%$2531.6
B0GTYBWVW3LILICARE2026-03-26Yes$36.99200pcs$7398.033.68%$2491.65
B0GF2B1TPZNUISM2026-03-09Yes$27.25200pcs$5450.037.11%$2022.5
B0FWK16PN6NUISM2025-10-15Yes$29.99200pcs$5998.033.06%$1982.94
B0GY7LCYCKHILOTUX2026-04-23Yes$27.75200pcs$5550.030.78%$1708.29
B0FY65M7TNYAAHARO2025-12-29Yes$17.79200pcs$3558.026.64%$947.86B0FT7SVVX7CFILIHTC2025-12-04Yes$19.99200pcs$3998.022.7%$907.55
B0GDS357K4Micro Ingredients2026-01-02Yes$13.17300pcs$3951.016.91%$668.12
B0GTQ6BDWXYAAHARO2026-05-21Yes$25.1950pcs$1259.529.36%$369.79#New Product Success Rates
Listing这个市场不适合进入，已经偏向价格战和高度拥挤。新产品整体盈利率只有40.00%，而未盈利新产品占56.52%；老品牌新产品盈利率33.33%、未盈利58.33%，说明连老玩家都在被压利润，市场不是增量机会，而是存量厮杀。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
OtherNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Snap SupplementsOther#Success Rate by Entry Time
Listing结论很明确：这个市场不值得进入，属于高竞争、接近价格战的危险区。 近一年新品牌持续进入，但成功率只有40%，且新品牌的失败率更高（52.38%），说明新进入者并没有形成稳定优势；用户预算50万CNY虽然覆盖单个新品的启动成本，但在这个市场里并不等于能拿到胜率。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 2 6 1 8 2026 0 0 0 1 1 9 0 22 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 1 0 1 2025/8 0 0 0 0 0 1 0 1 2025/9 0 0 0 0 0 0 0 3 2025/10 0 0 0 0 0 1 1 1 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 2 3 0 2 2026/1 0 0 0 1 0 1 0 5 2026/2 0 0 0 0 0 0 0 2 2026/3 0 0 0 0 0 6 0 6 2026/4 0 0 0 0 0 2 0 2 2026/5 0 0 0 0 1 0 0 2 2026/6 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases
NOW FoodsB0013OVX58 (4.6/5 (7310 Reviews))NOW Foods Supplements, L-Arginine 500 mg, Nitric Oxide Precursor*, Amino Acid, 250 Veg Capsules
This listing is deemed profitablePrice (USD)$16.37Released TypeOld Release (2013-10-08)Brand is an old entry in this marketSize and Weight13.1 x 6.8 x 6.6 cm, 227.00gProfitable Factors
Based on old ASINEstablished brand with longevityLow pricing strategyKey Buying Motive
经典左旋精氨酸配方，作为一氧化氮前体，偏向基础款补充而非复杂复配。Target Customers
偏好大牌基础配方、想用更低预算获取日常一氧化氮/血流支持的人群。Early Investment
Investment
Monthly Revenue (Recent) (USD)$16,370.001000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight20.31% / 22.64%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight13.56% / 15.89%Peak / Non PeakSales & BSR Performance
Force FactorB09H3KZDKB (4.4/5 (4014 Reviews))Force Factor Total Beets Nitric Oxide Supplement
This listing is deemed profitablePrice (USD)$37.21Released TypeOld Release (2021-09-24)Brand is an old entry in this marketSize and Weight13.2 x 11.9 x 6.6 cm, 386.00gProfitable Factors
Established brand with longevityBased on old ASINKey Buying Motive
以甜菜根硝酸盐+葡萄籽复配，主打一氧化氮、血流和心血管支持Target Customers
关注心脏健康、循环和无刺激能量补充的长期保健用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$22,326.00600 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight35.17% / 36.43%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight30.12% / 31.38%Peak / Non PeakSales & BSR Performance
Loading samples... 8%